Intracranial hypertension

Seminars in Neurology

Volumn 28, Issue 5, 2008, Pages 690-702

  Bershad, Eric M ^a   Humphreis III, William E ^a   Suarez, Jose I ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Brain injury; Cerebral edema; Elevated; Intracranial hypertension; Intracranial pressure

Indexed keywords

ACETAZOLAMIDE; BARBITURIC ACID DERIVATIVE; FUROSEMIDE; INDOMETACIN; INSULIN; MANNITOL; NEUROMUSCULAR BLOCKING AGENT; PHENYTOIN; PROPOFOL; SODIUM CHLORIDE; STEROID; TROMETAMOL;

ANESTHESIA; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; BLOOD PRESSURE; BODY POSITION; BODY TEMPERATURE; BRAIN BLOOD FLOW; BRAIN DEATH; BRAIN EDEMA; BRAIN HERNIA; BRAIN SURGERY; CEREBROSPINAL FLUID DRAINAGE; CRANIECTOMY; ELECTROLYTE DISTURBANCE; HEMODYNAMICS; HUMAN; HYPERBARIC OXYGEN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTRIGLYCERIDEMIA; HYPERVENTILATION; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; HYPOTENSION; HYPOVOLEMIA; INDUCED HYPOTHERMIA; INFECTION; INTENSIVE CARE UNIT; INTERVENTION STUDY; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; INTRACRANIAL PRESSURE MONITORING; KIDNEY FAILURE; LUNG EDEMA; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; MYOPATHY; NEUROIMAGING; NEUROMUSCULAR BLOCKING; OUTCOME ASSESSMENT; PARALYSIS; PATHOPHYSIOLOGY; PHYSICAL DISEASE BY BODY FUNCTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SEIZURE; STRESS ULCER; SURGICAL TECHNIQUE;

ACUTE DISEASE; BRAIN; BRAIN EDEMA; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; HUMANS; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; WATER-ELECTROLYTE BALANCE;

EID: 58849123145     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0028-1105968     Document Type: Review

References (103)

1. Kshettry VR, Mindea SA, Batjer HH. The management of cranial injuries in antiquity and beyond. Neurosurg Focus 2007;23(1):E8
2. Steiner LA, Andrews PJ. Monitoring the injured brain: ICP and CBF. Br J Anaesth 2006;97(1):26-38
3. Rangel-Castillo L, Robertson CS. Management of intracranial hypertension. Crit Care Clin 2006;22(4):713-732 abstract ix
4. Davson H, Hollingsworth G, Segal MB. The mechanism of drainage of the cerebrospinal fluid. Brain 1970;93(4):665-678
5. Czosnyka M, Richards HK, Czosnyka Z, et al. Vascular components of cerebrospinal fluid compensation. J Neurosurg 1999;90(4):752-759
6. Langfitt TW, Weinstein JD, Kassell NF. Cerebral vasomotor paralysis produced by intracranial hypertension. Neurology 1965;15:622-641
7. Stoyka WW, Frankel DZ, Kay JC. The linear relation of cerebral blood flow to arterial oxygen saturation in hypoxic hypoxia induced with nitrous oxide or nitrogen. Can Anaesth Soc J 1978;25(6):474-478
8. Klatzo I. Presidential address. Neuropathological aspects of brain edema. J Neuropathol Exp Neurol 1967;26(1):1-14
9. Black K. Blood-brain barrier. In: Youmans JR, ed. Neurological Surgery. Philadelphia: Saunders; 1995:482-490
10. Carpenter J, Weinstein S, Myseros J, Vezina G, Bell MJ. Inadvertent hyponatremia leading to acute cerebral edema and early evidence of herniation. Neurocrit Care 2007;6(3):195-199
11. Ropper AH. Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass. N Engl J Med 1986;314(15):953-958
12. Bingaman WE, Frank JI. Malignant cerebral edema and intracranial hypertension. Neurol Clin 1995;13(3):479-509
13. Kishore PR, Lipper MH, Becker DP, Domingues da Silva AA, Narayan RK. Significance of CT in head injury: correlation with intracranial pressure. AJR Am J Roentgenol 1981;137(4):829-833
14. Lee KR, Hoff JT. Intracranial Pressure. In: Youmans JR, ed. Neurological Surgery. Philadelphia: Saunders; 1996:491-518
15. Lyons MK, Meyer FB. Cerebrospinal fluid physiology and the management of increased intracranial pressure. Mayo Clin Proc 1990;65(5):684-707
16. Lang EW, Chesnut RM. Intracranial pressure. Monitoring and management. Neurosurg Clin N Am 1994;5(4):573-605
17. Jordan KG. Neurophysiologic monitoring in the neuroscience intensive care unit. Neurol Clin 1995;13(3):579-626
18. King WA, Martin NA. Critical care of patients with subarachnoid hemorrhage. Neurosurg Clin N Am 1994;5(4):767-787
19. Lundberg N. Continuous recording and control of ventricular fluid pressure in neurosurgical practice. Acta Psychiatr Scand Suppl 1960;36(149):1-193
20. Andrews BT, Chiles BW III, Olsen WL, Pitts LH. The effect of intracerebral hematoma location on the risk of brain-stem compression and on clinical outcome. J Neurosurg 1988;69(4):518-522
21. Feen ES, Suarez JI. Raised intracranial pressure. Curr Treat Options Neurol 2005;7(2):109-117
22. Frank JI. Management of intracranial hypertension. Med Clin North Am 1993;77(1):61-76
23. Winkelman C. Effect of backrest position on intracranial and cerebral perfusion pressures in traumatically brain-injured adults. Am J Crit Care 2000;9(6):373-380; quiz 381-372
24. Mitchell PH, Ozuna J, Lipe HP. Moving the patient in bed: effects on intracranial pressure. Nurs Res 1981;30(4):212-218
25. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. I. Blood pressure and oxygenation. J Neurotrauma 2007;(24 Suppl 1):S7-S13
26. Rosner MJ, Becker DP. Origin and evolution of plateau waves. Experimental observations and a theoretical model. J Neurosurg 1984;60(2):312-324
27. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. J Neurotrauma 2007;(24 Suppl 1):S59-S64
28. Robertson CS, Valadka AB, Hannay HJ, et al. Prevention of secondary ischemic insults after severe head injury. Crit Care Med 1999;27(10):2086-2095
29. Nordstrom CH. Physiological and biochemical principles underlying volume-targeted therapy-the "Lund concept". Neurocrit Care 2005;2(1):83-95
30. Yundt KD, Diringer MN. The use of hyperventilation and its impact on cerebral ischemia in the treatment of traumatic brain injury. Crit Care Clin 1997;13(1):163-184
31. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. XIV. Hyperventilation. J Neurotrauma 2007;(24 Suppl 1):S87-S90
32. McGuire G, Crossley D, Richards J, Wong D. Effects of varying levels of positive end-expiratory pressure on intracranial pressure and cerebral perfusion pressure. Crit Care Med 1997;25(6):1059-1062
33. Cooper KR, Boswell PA, Choi SC. Safe use of PEEP in patients with severe head injury. J Neurosurg 1985;63(4):552-555
34. Castillo J, Davalos A, Marrugat J, Noya M. Timing for fever-related brain damage in acute ischemic stroke. Stroke 1998;29(12):2455-2460
35. Hajat C, Hajat S, Sharma P. Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke 2000;31(2):410-414
36. Oliveira-Filho J, Ezzeddine MA, Segal AZ, et al. Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology 2001;56(10):1299-1304
37. Jiang JY, Gao GY, Li WP, Yu MK, Zhu C. Early indicators of prognosis in 846 cases of severe traumatic brain injury. J Neurotrauma 2002;19(7):869-874
38. Rossi S, Zanier ER, Mauri I, Columbo A, Stocchetti N. Brain temperature, body core temperature, and intracranial pressure in acute cerebral damage. J Neurol Neurosurg Psychiatry 2001;71(4):448-454
39. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32(10):2426-2432
40. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 1983;74(4):540-544
41. Els T, Klisch J, Orszagh M, et al. Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc Dis 2002;13(2):89-94
42. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001;57(9):1603-1610
43. Alberti O, Becker R, Benes L, Wallenfang T, Bertalanffy H. Initial hyperglycemia as an indicator of severity of the ictus in poor-grade patients with spontaneous subarachnoid hemorrhage. Clin Neurol Neurosurg 2000;102(2):78-83
44. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000;46(2):335-342; discussion 342-333
45. Yang SY, Zhang S, Wang ML. Clinical significance of admission hyperglycemia and factors related to it in patients with acute severe head injury. Surg Neurol 1995;44(4):373-377
46. Godoy DA, Pinero GR, Svampa S, Papa F, Di Napoli M. Hyperglycemia and short-term outcome in patients with spontaneous intracerebral hemorrhage. Neurocrit Care 2008;9:217-229
47. Kimura K, Iguchi Y, Inoue T, et al. Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage. J Neurol Sci 2007;255(1-2):90-94
48. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345(19):1359-1367
49. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354(5):449-461
50. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005;64(8):1348-1353
51. Bilotta F, Caramia R, Cernak I, et al. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocrit Care 2008;9:159-166
52. Vespa PM, Miller C, McArthur D, et al. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med 2007;35(12):2830-2836
53. Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized, double-blind study of phenytoin for the prevention of posttraumatic seizures. N Engl J Med 1990;323(8):497-502
54. Rosengart AJ, Huo JD, Tolentino J, et al. Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J Neurosurg 2007;107(2):253-260
55. Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS. Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 2004;79(12):1489-1494
56. Chen HJ, Lee TC, Wei CP. Treatment of cerebellar infarction by decompressive suboccipital craniectomy. Stroke 1992;23(7):957-961
57. Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007;6(3):215-222
58. Piek J. Decompressive surgery in the treatment of traumatic brain injury. Curr Opin Crit Care 2002;8(2):134-138
59. Muizelaar JP, van der Poel HG, Li ZC, Kontos HA, Levasseur JE. Pial arteriolar vessel diameter and CO2 reactivity during prolonged hyperventilation in the rabbit. J Neurosurg 1988;69(6):923-927
60. Marshall RS, Mayer SA. On Call Neurology. 2nd ed. New York: WB Saunders; 2001
61. Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg 1991; 75(5):731-739
62. de los Reyes RA, Ausman JI, Diaz FG. Agents for cerebral edema. Clin Neurosurg 1981;28:98-107
63. Nau R. Osmotherapy for elevated intracranial pressure: a critical reappraisal. Clin Pharmacokinet 2000;38(1):23-40
64. Ravussin P, Abou-Madi M, Archer D, et al. Changes in CSF pressure after mannitol in patients with and without elevated CSF pressure. J Neurosurg 1988;69(6):869-876
65. Mendelow AD, Teasdale GM, Russell T, et al. Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury. J Neurosurg 1985;63(1):43-48
66. Burke AM, Quest DO, Chien S, Cerri C. The effects of mannitol on blood viscosity. J Neurosurg 1981;55(4):550-553
67. Tan G, Zhou J, Yuan D, Sun S. Formula for use of mannitol in patients with intracerebral haemorrhage and high intracranial pressure. Clin Drug Investig 2008;28(2):81-87
68. Cruz J, Minoja G, Okuchi K, Facco E. Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial. J Neurosurg 2004;100(3):376-383
69. Garcia-Morales EJ, Cariappa R, Parvin CA, Scott MG, Diringer MN. Osmole gap in neurologic-neurosurgical intensive care unit: Its normal value, calculation, and relationship with mannitol serum concentrations. Crit Care Med 2004;32(4):986-991
70. Node Y, Nakazawa S. Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon. In: Long DM, ed. Brain Edema: Pathogenesis, Imaging and Therapy Advances in Neurology. New York: Raven Press; 1990:359-363
71. Domaingue CM, Nye DH. Hypotensive effect of mannitol administered rapidly. Anaesth Intensive Care 1985;13(2):134-136
72. Wakai A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev 2007;(1):CD001049
73. Bereczki D, Fekete I, Prado GF, Liu M. Mannitol for acute stroke. Cochrane Database Syst Rev 2007;(3):CD001153
74. Qureshi AI, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 2000;28(9):3301-3313
75. Qureshi AI, Suarez JI, Bhardwaj A, et al. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain. Crit Care Med 1998;26(3):440-446
76. Suarez JI. Hypertonic saline for cerebral edema and elevated intracranial pressure. Cleve Clin J Med 2004;71(S1):S9-S13
77. Koenig MA, Bryan M, Lewin JL III, et al. Reversal of transtentorial herniation with hypertonic saline. Neurology 2008;70:1023-1029
78. Harutjunyan L, Holz C, Rieger A, et al. Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients: a randomized clinical trial. Crit Care 2005;9(5):R530-R540
79. Roberts I. Barbiturates for acute traumatic brain injury. Cochrane Database Syst Rev 2000;(2):CD000033
80. Albanese J, Arnaud S, Rey M, et al. Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation. Anesthesiology 1997;87(6):1328-1334
81. Kolenda H, Gremmelt A, Rading S, Braun U, Markakis E. Ketamine for analgosedative therapy in intensive care treatment of head-injured patients. Acta Neurochir (Wien) 1996;138(10):1193-1199
82. Ubogu EE, Sagar SM, Lerner AJ, et al. Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity. Epilepsy Behav 2003;4(1):70-75
83. Minton MD, Grosslight K, Stirt JA, Bedford RF. Increases in intracranial pressure from succinylcholine: prevention by prior nondepolarizing blockade. Anesthesiology 1986;65(2):165-169
84. Markewitz BA, Elstad MR. Succinylcholine-induced hyperkalemia following prolonged pharmacologic neuromuscular blockade. Chest 1997;111(1):248-250
85. Clifton GL, Miller ER, Choi SC, et al. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 2001;344(8):556-563
86. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346(8):557-563
87. Padosch SA, Kern KB, Bottiger BW. Therapeutic hypothermia after cardiac arrest. N Engl J Med 2002;347(1):63-65; author reply 63-65
88. Poungvarin N, Bhoopat W, Viriyavejakul A, et al. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 1987;316(20):1229-1233
89. Qizilbash N, Lewington SL, Lopez-Arrieta JM. Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev 2002;(2):CD000064
90. Norris JW, Hachinski VC. High dose steroid treatment in cerebral infarction. Br Med J (Clin Res Ed) 1986;292(6512):21-23
91. Anderson DC, Cranford RE. Corticosteroids in ischemic stroke. Stroke 1979;10(1):68-71
92. Bauer RB, Tellez H. Dexamethasone as treatment in cerebrovascular disease. 2. A controlled study in acute cerebral infarction. Stroke 1973;4(4):547-555
93. Chen D, Nishizawa S, Yokota N, et al. High-dose methylprednisolone prevents vasospasm after subarachnoid hemorrhage through inhibition of protein kinase C activation. Neurol Res 2002;24(2):215-222
94. Chyatte D, Fode NC, Nichols DA, Sundt TM Jr. Preliminary report: effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1987;21(2):157-160
95. Yamakawa K, Sasaki T, Tsubaki S, et al. Effect of high-dose methylprednisolone on vasospasm after subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 1991;31(1):24-31
96. Edwards P, Arango M, Balica L, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 2005;365(9475):1957-1959
97. Kullberg G, West KA. Influence of corticosteroids on the ventricular fluid pressure. Acta Neurol Scand Suppl 1965; 13(Pt 2):445-452
98. Miller JD, Sakalas R, Ward JD, et al. Methylprednisolone treatment in patients with brain tumors. Neurosurgery 1977;1(2):114-117
99. Naredi S, Olivecrona M, Lindgren C, et al. An outcome study of severe traumatic head injury using the "Lund therapy" with low-dose prostacyclin. Acta Anaesthesiol Scand 2001;45(4):402-406
100. Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: management protocol and clinical results. J Neurosurg 1995;83(6):949-962
101. Nordstrom CH. Volume-targeted therapy of increased intracranial pressure. Acta Neurochir Suppl 2003;86:355-360
102. Eker C, Asgeirsson B, Grande PO, Schalen W, Nordstrom CH. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation. Crit Care Med 1998;26(11):1881-1886
103. Brazis PW, Masdeu JC, Biller J. Coma. In: Brazis PW, Masdeu JC, Biller J, eds. Localization in Clinical Neurology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2001:559-585